Milestone Scientific Inc (NYSEAMERICAN:MLSS), a leading developer of computerized drug delivery instruments that provide virtually painless and precise injections, said Tuesday it has begun selling CompuFlo/CathCheck disposables to the Medical University of South Carolina (MUSC).
The MUSC University Medical Center is a nationally recognized and leading health sciences university, recently ranked as the number one hospital in South Carolina, the company noted. MUSC Health owns and operates eight hospitals and provides patient care throughout the state.
“This latest commercial order follows extensive testing on the part of the MUSC team,” said Milestone Scientific president Arjan Haverhals in a statement. “This decision by another leading U.S. medical center further illustrates the favorable response to both CathCheck and CompuFlo as we execute on our goal to become the new standard of care in epidural procedures.”
READ: Milestone Scientific begins sales of CompuFlo epidural instruments and disposables to University Hospital of Wurzburg
Milestone Scientific said the clinical and safety benefits of the CompuFlo Epidural/CathCheck System are backed by extensive published clinical data demonstrating significant reductions in epidural punctures and complication rates as well as time-savings on the part of anesthesiologists.
Moreover, the CompuFlo instrument has the potential to significantly reduce costs associated with morbidity, providing a direct economic benefit to healthcare institutions. Similarly, the CathCheck technology has the potential to transform the monitoring of catheter placement following an epidural procedure by confirming the placement of a catheter within two minutes, versus 20-40 minutes using conventional methods.
Contact the author: patrick@proactiveinvestors.com
Follow him on Twitter @PatrickMGraham